Gabriele Nicolini

Gabriele Nicolini has extensive work experience in the pharmaceutical industry. In 1999, they started as a sales representative at Chiesi Italia and later became a Trainer of the sales force. In 2000, they served as the Technical Director at Faustfarm S.p.A. Gabriele returned to Chiesi Italia in 2001 and held various roles, including Medical Advisor and Medical Manager, specializing in respiratory, antibiotics, and allergology areas. From 2013 to 2022, Nicolini worked at Chiesi Group, where they served as Head of International and Late Phase Studies, Head of Emerging Countries and Phase IV Studies, Global Medical Affairs Head, and Head of Global Medical Affairs & Patient Advocacy. In 2022, they joined PIAM Farmaceutici S.p.A. and Bruschettini Farmaceutici as the Medical Director. Prior to joining PIAM Farmaceutici S.p.A., they held the position of Global Medical Affairs Leader.

Gabriele Nicolini pursued a doctoral degree in Experimental Respiratory Pathophysiology from Università degli Studi di Parma, starting in 2007 and completing the program in 2009. Prior to that, in 1997, they obtained a Pharmacist professional abilitation from Università degli Studi di Urbino Carlo Bo. Additionally, they received a Laurea in Farmacia from Università degli Studi di Milano, although the specific field of study for this degree is not mentioned.